Clinical Trial Update: Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Tozorakimab in hospitalized patients with viral lung infection requiring supplemental oxygen is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure
• Viral Pneumonia

Drugs mentioned

• Tozorakimab (tozorakimab)

Snippet

Sponsor: AstraZeneca | Conditions: Viral Lung Infection and Acute Respiratory Failure | Phase 3 | Status: RECRUITING